Epicardial adipose tissue and insulin resistance in obese subjects

Gianluca Iacobellis, Frida Leonetti

Research output: Contribution to journalArticle

225 Citations (Scopus)

Abstract

Context: Epicardial adipose tissue has been recently recognized as a source of bioactive molecules as well as free fatty acids, adiponectin, and inflammatory cytokines. Epicardial fat reflects intraabdominal visceral fat, and the echocardiographic assessment of this tissue is an easy and reliable marker of visceral adiposity. Objective: In this study we evaluated whether epicardial adipose tissue is related to insulin sensitivity and glucose metabolism in obese subjects. Patients: Thirty obese subjects (20 women and 10 men; mean age, 40.8 ± 11.5 yr; body mass index, 43 ± 9.1 kg/m2) were included in this study. No subject was taking drugs or had a history or evidence of metabolic, cardiovascular, respiratory, or hepatic disease. Main Outcome Measures: Each subject underwent a transthoracic echocardiogram to evaluate epicardial adipose tissue thickness, a euglycemic hyperinsulinemic clamp to estimate insulin sensitivity, and an oral glucose tolerance test to evaluate glucose tolerance. Results: The thickness of the epicardial adipose tissue on the right ventricle varied between 4 and 17.4 mm. Echocardiographic epicardial adipose tissue was significantly correlated with whole-body glucose uptake index from the clamp and with all indices of insulin resistance and glucose intolerance measured, except the 120-min plasma glucose level after an oral glucose tolerance test. Conclusions: Our study showed that the epicardial fat is significantly related to obesity-related insulin resistance. This finding could be of potential interest in clinical practice and research of obesity-related risk stratification.

Original languageEnglish
Pages (from-to)6300-6302
Number of pages3
JournalJournal of Clinical Endocrinology and Metabolism
Volume90
Issue number11
DOIs
StatePublished - Nov 1 2005
Externally publishedYes

Fingerprint

Insulin Resistance
Adipose Tissue
Insulin
Tissue
Glucose
Glucose Tolerance Test
Fats
Clamping devices
Obesity
Glucose Clamp Technique
Glucose Intolerance
Intra-Abdominal Fat
Adiponectin
Adiposity
Nonesterified Fatty Acids
Heart Ventricles
Body Mass Index
History
Outcome Assessment (Health Care)
Metabolism

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Epicardial adipose tissue and insulin resistance in obese subjects. / Iacobellis, Gianluca; Leonetti, Frida.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 90, No. 11, 01.11.2005, p. 6300-6302.

Research output: Contribution to journalArticle

@article{ba1624fab3474abd8c29f6aa5e992c3e,
title = "Epicardial adipose tissue and insulin resistance in obese subjects",
abstract = "Context: Epicardial adipose tissue has been recently recognized as a source of bioactive molecules as well as free fatty acids, adiponectin, and inflammatory cytokines. Epicardial fat reflects intraabdominal visceral fat, and the echocardiographic assessment of this tissue is an easy and reliable marker of visceral adiposity. Objective: In this study we evaluated whether epicardial adipose tissue is related to insulin sensitivity and glucose metabolism in obese subjects. Patients: Thirty obese subjects (20 women and 10 men; mean age, 40.8 ± 11.5 yr; body mass index, 43 ± 9.1 kg/m2) were included in this study. No subject was taking drugs or had a history or evidence of metabolic, cardiovascular, respiratory, or hepatic disease. Main Outcome Measures: Each subject underwent a transthoracic echocardiogram to evaluate epicardial adipose tissue thickness, a euglycemic hyperinsulinemic clamp to estimate insulin sensitivity, and an oral glucose tolerance test to evaluate glucose tolerance. Results: The thickness of the epicardial adipose tissue on the right ventricle varied between 4 and 17.4 mm. Echocardiographic epicardial adipose tissue was significantly correlated with whole-body glucose uptake index from the clamp and with all indices of insulin resistance and glucose intolerance measured, except the 120-min plasma glucose level after an oral glucose tolerance test. Conclusions: Our study showed that the epicardial fat is significantly related to obesity-related insulin resistance. This finding could be of potential interest in clinical practice and research of obesity-related risk stratification.",
author = "Gianluca Iacobellis and Frida Leonetti",
year = "2005",
month = "11",
day = "1",
doi = "10.1210/jc.2005-1087",
language = "English",
volume = "90",
pages = "6300--6302",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "11",

}

TY - JOUR

T1 - Epicardial adipose tissue and insulin resistance in obese subjects

AU - Iacobellis, Gianluca

AU - Leonetti, Frida

PY - 2005/11/1

Y1 - 2005/11/1

N2 - Context: Epicardial adipose tissue has been recently recognized as a source of bioactive molecules as well as free fatty acids, adiponectin, and inflammatory cytokines. Epicardial fat reflects intraabdominal visceral fat, and the echocardiographic assessment of this tissue is an easy and reliable marker of visceral adiposity. Objective: In this study we evaluated whether epicardial adipose tissue is related to insulin sensitivity and glucose metabolism in obese subjects. Patients: Thirty obese subjects (20 women and 10 men; mean age, 40.8 ± 11.5 yr; body mass index, 43 ± 9.1 kg/m2) were included in this study. No subject was taking drugs or had a history or evidence of metabolic, cardiovascular, respiratory, or hepatic disease. Main Outcome Measures: Each subject underwent a transthoracic echocardiogram to evaluate epicardial adipose tissue thickness, a euglycemic hyperinsulinemic clamp to estimate insulin sensitivity, and an oral glucose tolerance test to evaluate glucose tolerance. Results: The thickness of the epicardial adipose tissue on the right ventricle varied between 4 and 17.4 mm. Echocardiographic epicardial adipose tissue was significantly correlated with whole-body glucose uptake index from the clamp and with all indices of insulin resistance and glucose intolerance measured, except the 120-min plasma glucose level after an oral glucose tolerance test. Conclusions: Our study showed that the epicardial fat is significantly related to obesity-related insulin resistance. This finding could be of potential interest in clinical practice and research of obesity-related risk stratification.

AB - Context: Epicardial adipose tissue has been recently recognized as a source of bioactive molecules as well as free fatty acids, adiponectin, and inflammatory cytokines. Epicardial fat reflects intraabdominal visceral fat, and the echocardiographic assessment of this tissue is an easy and reliable marker of visceral adiposity. Objective: In this study we evaluated whether epicardial adipose tissue is related to insulin sensitivity and glucose metabolism in obese subjects. Patients: Thirty obese subjects (20 women and 10 men; mean age, 40.8 ± 11.5 yr; body mass index, 43 ± 9.1 kg/m2) were included in this study. No subject was taking drugs or had a history or evidence of metabolic, cardiovascular, respiratory, or hepatic disease. Main Outcome Measures: Each subject underwent a transthoracic echocardiogram to evaluate epicardial adipose tissue thickness, a euglycemic hyperinsulinemic clamp to estimate insulin sensitivity, and an oral glucose tolerance test to evaluate glucose tolerance. Results: The thickness of the epicardial adipose tissue on the right ventricle varied between 4 and 17.4 mm. Echocardiographic epicardial adipose tissue was significantly correlated with whole-body glucose uptake index from the clamp and with all indices of insulin resistance and glucose intolerance measured, except the 120-min plasma glucose level after an oral glucose tolerance test. Conclusions: Our study showed that the epicardial fat is significantly related to obesity-related insulin resistance. This finding could be of potential interest in clinical practice and research of obesity-related risk stratification.

UR - http://www.scopus.com/inward/record.url?scp=27744581763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27744581763&partnerID=8YFLogxK

U2 - 10.1210/jc.2005-1087

DO - 10.1210/jc.2005-1087

M3 - Article

VL - 90

SP - 6300

EP - 6302

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 11

ER -